Enhancing Single‐Domain Antibody‐Based Protein Degradation for Synucleinopathies
Yixiang Jiang · 2025
Read Enhancing Single‐Domain Antibody‐Based Protein Degradation for Synucleinopathies by Yixiang Jiang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710823.txt.
Description
Yixiang Jiang reports a 2025 mouse study of a small antibody tool against alpha-synuclein, the protein that clumps in Parkinson's-like diseases. Full antibodies are too large to enter the brain well. Single-domain antibodies are ten times smaller and reach the brain far better. Jiang's team had built such a tool, called 2D8, that binds the protein.
The team linked 2D8 to a drug tag, making a version that sends the protein to the cell's shredder. In cell tests the new version cleared the protein and blocked its toxic effect. In mice, three doses cut the brain signal of the protein by about four fifths, far more than the plain tool. Lab checks confirmed deep clearance with no clear harm.
Catalog record
| CREATOR | Yixiang Jiang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |